American Lung Association slams cigarette maker for inhaled medical therapy acquisition

The American Lung Association condemned the recently announced acquisition of Vectura by cigarette maker Philip Morris (NYSE:PM).

Earlier this month, Philip Morris announced that it agreed to acquire inhaled drug delivery technology developer Vectura for $1.2 billion.

In response to the acquisition, American Lung Association president & CEO Harold Wimmer and American Thoracic Society president Dr. Lynn Schnapp released a joint statement calling the purchase “the latest reprehensible choice from a company that has profited from addicting users to its deadly products.”

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0